On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
Author:
- 1 January 2015
- journal article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 43 (1) , 134-142
Abstract
This paper examines three possible justifications for original ACMG recommendations to return incidental findings from whole exome or genome sequencing independent of patient preferences. The first two potential justifications, based on a patient's authentic values, then on harms to others, are founding lacking as a basis of justification for these recommendations. The third, grounded in analogous professional practices, might serve as a potential justification if several controversies can be avoided. However, given the nature of these controversies and the need to instill public trust in this newly emerging science, the paper finds that updated ACMG recommendations that recognize opt-out rights on behalf of patients is the most prudent, and justifiable, approach.Keywords
This publication has 7 references indexed in Scilit:
- An Adoptive Parental Perspective on Personal Genomic ScreeningPediatrics, 2015
- Views of primary care providers regarding the return of genome sequencing incidental findingsClinical Genetics, 2014
- Reporting Genomic Sequencing Results to Ordering CliniciansJAMA, 2013
- Ethics and Genomic Incidental FindingsScience, 2013
- Return of Unexpected DNA Results UrgedScience, 2013
- Rethinking clinical risk for DNA sequencing.The American Journal of Bioethics, 2012
- Autonomy, Full Information, and Genetic Ignorance in Reproductive MedicineThe Monist, 2006